GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

EU seeks to access AstraZeneca vaccines produced in U.S.- FT

Sat, 06th Mar 2021 09:18

March 6 (Reuters) - The European Union will urge the United
States to permit the export of millions of doses of
AstraZeneca's COVID-19 vaccine to Europe, underlining
Brussels' scramble to bridge supply shortfalls, the Financial
Times reported on Saturday.

The EU also wants Washington to ensure the free flow of
shipments of crucial vaccine ingredients needed in European
production, according to the FT.

"We trust that we can work together with the U.S. to ensure
that vaccines produced or bottled in the U.S. for the fulfilment
of vaccine producers' contractual obligations with the EU will
be fully honoured,” the newspaper quoted the European Commission
as saying.
(Reporting by Ann Maria Shibu in Bengaluru
Editing by Mark Heinrich)

Related Shares

More News
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

5 Jun 2024 09:27

AstraZeneca completes USD2.4 billion Fusion Pharmaceuticals purchase

(Alliance News) - AstraZeneca PLC on Wednesday said it successfully completed the acquisition of Boston, Massachusetts-based Fusion Pharmaceuticals In...

3 Jun 2024 08:59

AstraZeneca cancer treatment Tagrisso recommended for approval in EU

(Alliance News) - AstraZeneca PLC said that, following further positive findings in clinical trial, Tagrisso has been recommended for use in the Europ...

3 Jun 2024 07:28

AstraZeneca's lung cancer treatment recommended for approval in EU

(Sharecast News) - AstraZeneca has announced that its Tagrisso treatment for advanced lung cancer, when combined with chemotherapy, has been recommend...

2 Jun 2024 20:03

Astra's Enhertu breast cancer trial shows 'unprecedented' results

June 2 (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu slows the progression of breast cancer by about five months in women whose disease worse...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.